Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
55 /100
HIGH RISK
Score updated Jul 28, 2026

ADVB — Advanced Biomed Inc. Dilution Risk Tracker

Track ADVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADVB — Get alerts when the score changes →

As of July 28, 2026, Advanced Biomed Inc. (ADVB) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Advanced Biomed Inc. has a market capitalization of $8.19M, 1.38M shares outstanding, 3 institutional holders tracked. Key dilution vectors include approximately 5 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

Watch
Minor dilution signals detected
17%
💰 Capital Raise 35%
• Low cash runway: 5 months remaining
🔔 Track ADVB — Get forecast alerts →

Market Data

Market Cap$8.19M
Shares Outstanding1.38M
Float629.7K
Cash$2.60M
Debt$712.5K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 83.2% shares (2025Q4 vs prior)
3 institutional holders · 44.1K shares
#1 XTX Topco Ltd 27.3K shares
#2 Virtu Financial LLC 12.6K shares
#3 UBS Group AG 4.3K shares

Short Interest

Short Interest10.6K
Days to Cover1.0
% of Float1.7%
FINRA data as of Jul 15, 2026

Recent SEC Activity

8-K 8K EVENT 2026-05-01
8-K 8K EVENT 2026-04-03
8-K/A 8K EVENT 2026-02-10
8-K 8K EVENT 2026-02-02
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for ADVB Shareholders

Advanced Biomed Inc. (ADVB) has a DilutionScore of 55/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 28, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: ADVB has approximately 5 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ADVB in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch shows real-time score changes for ADVB alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding ADVB's Dilution Risk Factors

Primary Risk Drivers

The most concerning factors for Advanced Biomed Inc. are Offering Ability and Cash Runway. Offering Ability scores at a level indicating significant potential for new capital raises, which directly increases the risk of dilution. This score suggests that the company is actively pursuing ways to raise funds through equity offerings, potentially at the expense of existing shareholders' ownership. Cash Runway is equally problematic, scoring at a level that signals near-term liquidity concerns. A low cash runway means the company may be forced to seek additional capital quickly, further increasing the risk of dilution through new share issuance.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently at levels indicating minimal threat. Float Risk is relatively low, suggesting that a small portion of shares are actively traded, reducing immediate dilution pressures from market liquidity issues. Warrant Exposure is similarly low, meaning the company has not issued a large number of warrants that could dilute current shareholders. A change in either area would raise concerns: an increase in float risk would occur if more shares became available for trading; an uptick in warrant exposure would happen if new warrants were issued without corresponding increases in share price or investor interest.

SEC Filings to Watch

Several SEC filings are critical to monitor for signs of increased dilution. An S-3 registration statement signals a potential large-scale offering, which could significantly increase the share count. A 424B5 filing indicates a planned offering or distribution of securities and should be tracked closely. An 8-K Item 1.01 announcement typically reports a material event such as a new equity offering or significant capital raise. Additionally, a 10-Q filing may reveal changes in financial position or strategic plans that could lead to dilution, especially if cash reserves are declining or new funding is being sought.

How Dilution Happens

Dilution occurs when existing shareholders' ownership percentage decreases due to an increase in total shares outstanding. In ADVB’s case, elevated Offering Ability and Cash Runway scores suggest the company may be planning or executing equity offerings to raise capital. As these offerings are completed, new shares are issued, directly reducing the proportion of company ownership held by current investors. The process begins with the company filing for a new offering, followed by the actual issuance of shares, which then dilutes existing holdings.

What Would Make This Worse

The risk profile would deteriorate significantly if multiple dilution mechanisms were activated simultaneously. For example, if the company initiated an equity offering (raising Offering Ability), while also issuing warrants or convertible notes, it could lead to a rapid and substantial increase in shares outstanding. Additionally, if cash runway continues to decline without new capital raises, the company may be forced into more aggressive financing strategies, potentially including debt-to-equity conversions or rights offerings, all of which would further erode existing shareholder value.

Key Insight

While a low score indicates safety in this inverted scale, investors should monitor for increases in dilution risk factors that could lead to significant share count expansion and reduced ownership percentages for current shareholders.

How to Monitor ADVB for Dilution Risk

What This Risk Level Means

For an operating company like Advanced Biomed Inc., a high dilution risk profile indicates that the firm is likely relying heavily on equity issuance to fund operations, which can significantly erode shareholder value. As a micro-cap entity, ADVB operates with limited financial buffers and may face frequent capital raises, especially if it lacks consistent cash flow or access to debt markets. The inverted scale means that a score of 55/100 reflects a situation where dilution pressures are present but not yet critical — still within manageable bounds for a small company, though concerning enough to warrant active monitoring.

What Typically Happens Next

Companies at this profile often proceed with strategic capital-raising activities such as shelf registrations or ATM programs to secure funding. In some cases, warrants may be exercised, or convertible notes could convert into equity, increasing the risk of dilution. These actions typically occur in cycles, especially when a company is operating near cash runway limits. For ADVB, it's common to see these events unfold over 6–12 month periods, particularly if the company lacks strong profitability or stable cash generation.

Monitoring Playbook

To track dilution risk in ADVB, use DilutionWatch to set up alerts for any change in key factors such as Cash Runway, Offering Ability, and Warrant Exposure. Set thresholds at 5/100 intervals for each factor and review updates weekly. If a factor crosses a critical threshold — say, Offering Ability rising above 50/100 — immediately investigate recent SEC filings for new equity offerings or financing announcements. Additionally, monitor Shelf & ATM Monitor for any new registration filings related to the company.

Early Warning Signals

Several specific signals can indicate worsening dilution risk. First, a sudden spike in Offering Ability or Cash Runway scores suggests increased reliance on equity issuance. Second, a significant uptick in Warrant Exposure or Convertible Note Risk may point to upcoming conversions or exercises. Third, the filing of a new shelf registration or ATM program in SEC documents is a strong indicator that the company is preparing for a capital raise.

What a Positive Resolution Looks Like

A positive shift in ADVB’s dilution risk profile would occur if the company secures a major capital raise, reduces debt obligations, or sees warrant expiration without new issuances. A sustained improvement in Cash Runway score — for example, dropping below 70/100 — would also signal a healthier financial position. Additionally, a reduction in Offering Ability or Float Risk scores due to fewer planned equity issuances would indicate that the company is regaining control over its capital structure.

Watch For

Any sudden increase in Offering Ability or Cash Runway scores, especially if followed by new SEC filings indicating equity issuance plans.

Full SEC filing analysis available with free account  →
Track ADVB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ADVB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ADVB
ADVB FDA Catalyst Timeline & Biotech Grade — BiotechSignsADVB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.